Net Income (Loss) Attributable to Parent in USD of INTEGRATED BIOPHARMA INC from Q3 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Integrated Biopharma Inc quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2010 to Q3 2025.
  • Integrated Biopharma Inc Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was $123K, a 52.5% decline year-over-year.
  • Integrated Biopharma Inc Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was $672K, a 56.3% increase year-over-year.
  • Integrated Biopharma Inc annual Net Income (Loss) Attributable to Parent for 2025 was $808K, a 621% increase from 2024.
  • Integrated Biopharma Inc annual Net Income (Loss) Attributable to Parent for 2024 was $112K.
  • Integrated Biopharma Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$34K, a 101% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

INTEGRATED BIOPHARMA INC Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $672K $123K -$136K -52.5% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $808K -$178K -$446K -166% 01 Apr 2025 30 Jun 2025 10-K 23 Sep 2025
Q1 2025 $1.25M $611K +$326K +114% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $928K $116K +$498K 01 Oct 2024 31 Dec 2024 10-Q 14 May 2025
Q3 2024 $430K $259K +$318K 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 $112K $268K +$228K +570% 01 Apr 2024 30 Jun 2024 10-K 23 Sep 2025
Q1 2024 -$116K $285K +$269K +1681% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 -$385K -$382K -$327K -595% 01 Oct 2023 31 Dec 2023 10-Q 14 May 2025
Q3 2023 -$58K -$59K -$24K -68.6% 01 Jul 2023 30 Sep 2023 10-Q 14 May 2025
Q2 2023 -$34K $40K -$1.45M -97.3% 01 Apr 2023 30 Jun 2023 10-K 20 Sep 2024
Q1 2023 $1.42M $16K -$781K -98% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q4 2022 $2.2M -$55K -$1.09M -105% 01 Oct 2022 31 Dec 2022 10-Q 10 May 2024
Q3 2022 $3.29M -$35K -$551K -107% 01 Jul 2022 30 Sep 2022 10-Q 10 May 2024
Q2 2022 $3.84M $1.49M -$3.01M -66.9% 01 Apr 2022 30 Jun 2022 10-K 15 Sep 2023
Q1 2022 $6.85M $797K -$444K -35.8% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $7.3M $1.03M -$193K -15.8% 01 Oct 2021 31 Dec 2021 10-Q 11 May 2023
Q3 2021 $7.49M $516K -$525K -50.4% 01 Jul 2021 30 Sep 2021 10-Q 11 May 2023
Q2 2021 $8.01M $4.51M +$2.61M +137% 01 Apr 2021 30 Jun 2021 10-K 13 Sep 2022
Q1 2021 $5.41M $1.24M +$305K +32.6% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $5.1M $1.22M +$265K +27.6% 01 Oct 2020 31 Dec 2020 10-Q 12 May 2022
Q3 2020 $4.84M $1.04M +$729K +234% 01 Jul 2020 30 Sep 2020 10-Q 12 May 2022
Q2 2020 $4.11M $1.9M +$1.54M +428% 01 Apr 2020 30 Jun 2020 10-K 02 Sep 2021
Q1 2020 $2.57M $936K +$13K +1.41% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 $2.55M $959K +$713K +290% 01 Oct 2019 31 Dec 2019 10-Q 13 May 2021
Q3 2019 $1.84M $312K +$153K +96.2% 01 Jul 2019 30 Sep 2019 10-Q 13 May 2021
Q2 2019 $1.69M $360K -$458K -56% 01 Apr 2019 30 Jun 2019 10-K 23 Sep 2020
Q1 2019 $2.15M $923K +$535K +138% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q4 2018 $1.61M $246K +$594K 01 Oct 2018 31 Dec 2018 10-Q 13 May 2020
Q3 2018 $1.02M $159K +$338K 01 Jul 2018 30 Sep 2018 10-Q 13 May 2020
Q2 2018 $679K $818K 01 Apr 2018 30 Jun 2018 10-K 29 Aug 2019
Q1 2018 $388K +$150K +63% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 -$348K -$271K -352% 01 Oct 2017 31 Dec 2017 10-Q 15 May 2019
Q3 2017 -$179K -$828K -128% 01 Jul 2017 30 Sep 2017 10-Q 15 May 2019
Q1 2017 $238K +$205K +621% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q4 2016 -$77K -$14K -22.2% 01 Oct 2016 31 Dec 2016 10-Q 09 Feb 2018
Q3 2016 $649K +$408K +169% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q1 2016 $102K $33K +$139K 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017
Q4 2015 -$37K -$63K -$610K -112% 01 Oct 2015 31 Dec 2015 10-Q 10 Feb 2017
Q3 2015 $573K $241K -$162K -40.2% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016
Q2 2015 $735K -$109K +$5K +4.39% 01 Apr 2015 30 Jun 2015 10-K 02 Sep 2016
Q1 2015 $730K -$106K +$344K +76.4% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016
Q4 2014 $386K $547K +$150K +37.8% 01 Oct 2014 31 Dec 2014 10-Q 19 Feb 2016
Q3 2014 $236K $403K +$105K +35.2% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015
Q2 2014 $131K -$114K -$894K -115% 01 Apr 2014 30 Jun 2014 10-K 04 Sep 2015
Q1 2014 $1.03M -$450K +$82K +15.4% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015
Q4 2013 $943K $397K -$420K -51.4% 01 Oct 2013 31 Dec 2013 10-Q 17 Feb 2015
Q3 2013 $1.36M $298K +$1.27M 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014
Q2 2013 $93K $780K +$2.33M 01 Apr 2013 30 Jun 2013 10-K 08 Sep 2014
Q1 2013 -$2.24M -$532K +$206K +27.9% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014
Q4 2012 -$2.45M $817K +$1.6M 01 Oct 2012 31 Dec 2012 10-Q/A 13 Feb 2014
Q3 2012 -$4.05M -$972K -$1.34M -368% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 -$2.71M -$1.55M -$572K -58.3% 01 Apr 2012 30 Jun 2012 10-K 30 Sep 2013
Q1 2012 -$2.14M -$738K +$138K +15.8% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q4 2011 -$2.28M -$785K -$362K -85.6% 01 Oct 2011 31 Dec 2011 10-Q 19 Feb 2013
Q3 2011 -$1.92M $363K +$364K 01 Jul 2011 30 Sep 2011 10-Q 19 Nov 2012
Q2 2011 -$2.28M -$981K 01 Apr 2011 30 Jun 2011 10-K 15 Oct 2012
Q1 2011 -$876K 01 Jan 2011 31 Mar 2011 10-Q 21 May 2012
Q4 2010 -$423K 01 Oct 2010 31 Dec 2010 10-Q 21 Feb 2012
Q3 2010 -$1K 01 Jul 2010 30 Sep 2010 10-Q 21 Nov 2011

INTEGRATED BIOPHARMA INC Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $808K +$696K +621% 01 Jul 2024 30 Jun 2025 10-K 23 Sep 2025
2024 $112K +$146K 01 Jul 2023 30 Jun 2024 10-K 23 Sep 2025
2023 -$34K -$3.87M -101% 01 Jul 2022 30 Jun 2023 10-K 20 Sep 2024
2022 $3.84M -$4.18M -52.1% 01 Jul 2021 30 Jun 2022 10-K 15 Sep 2023
2021 $8.01M +$3.91M +95.1% 01 Jul 2020 30 Jun 2021 10-K 13 Sep 2022
2020 $4.11M +$2.42M +143% 01 Jul 2019 30 Jun 2020 10-K 02 Sep 2021
2019 $1.69M +$1.01M +149% 01 Jul 2018 30 Jun 2019 10-K 23 Sep 2020
2018 $679K +$818K 01 Jul 2017 30 Jun 2018 10-K 29 Aug 2019
2017 -$139K -$949K -117% 01 Apr 2017 31 Mar 2018 10-Q 09 May 2018
2016 $810K +$75K +10.2% 01 Apr 2016 31 Mar 2017 10-Q 09 May 2018
2015 $735K +$604K +461% 01 Jul 2014 30 Jun 2015 10-K 02 Sep 2016
2014 $131K +$38K +40.9% 01 Jul 2013 30 Jun 2014 10-K 04 Sep 2015
2013 $93K +$2.81M 01 Jul 2012 30 Jun 2013 10-K 08 Sep 2014
2012 -$2.71M -$432K -18.9% 01 Jul 2011 30 Jun 2012 10-K 30 Sep 2013
2011 -$2.28M 01 Jul 2010 30 Jun 2011 10-K 15 Oct 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.